Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-07-01 Sale |
2020-07-02 4:13 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
29,589 | $25.37 | $750,678 | 0 (Direct) |
View |
| 2020-06-10 Sale |
2020-06-12 5:50 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
13,752 | $25.07 | $344,763 | 141,778 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-30 Option Award |
2020-07-02 4:12 pm |
N/A 2030-06-29 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
18,760 | $0 | 18,760 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:12 pm |
N/A 2030-06-29 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director |
18,760 | $0 | 18,760 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:11 pm |
N/A 2030-06-29 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director |
18,760 | $0 | 18,760 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:11 pm |
N/A 2030-06-29 |
Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director |
18,760 | $0 | 18,760 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:50 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
13,752 | $1.59 | 141,778 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:50 pm |
N/A 2025-12-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
13,752 | $0 | 141,778 (Direct) |
View |
| 2020-05-18 Option Award |
2020-05-18 6:57 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
1,600,000 | $18.25 | 11,353,392 (Indirect) |
View |